MedTrace Logo

Enhancing the Efficacy of Smoking Quit Line in the Military (AFIII Renewal)

NCT02201810 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 614

Last updated 2022-05-26

No results posted yet for this study

Summary

This study is a randomized clinical trial designed to measure the effectiveness of three QL interventions for smokers who failed to quit an initial smoking cessation intervention, but remain motivated to quit smoking.

Conditions

  • Initial Efficacy of Quit Line
  • Efficacy of Secondary Reengagement Intervention

Interventions

BEHAVIORAL

Rate reduction intervention

BEHAVIORAL

Recycling Group

BEHAVIORAL

Choice Group

BEHAVIORAL

Proactive QL

Sponsors & Collaborators

  • University of Tennessee

    collaborator OTHER

  • University of Virginia

    lead OTHER

Principal Investigators

  • Robert Klesges, PhD · UTHSC

  • Wayne Talcott, PhD · UTHSC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2020-11-30
Completion
2020-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02201810 on ClinicalTrials.gov